Diseases & Conditions market research reports by DelveInsight

• Peripheral Neuropathic Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Peripheral Neuropathic Pain - Pipeline Insight, 2024 DelveInsight’s, “Peripheral Neuropathic Pain - Pipeline Insight, 2024,” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Peripheral Neuropathic Pain pipeline landscape. It covers the pipeline drug profiles, inclu ... Read More

• Anti-hypertension - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Anti-hypertension - Pipeline Insight, 2024 Anti-hypertension Overview ""Anti-hypertension Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Anti-hypertension market. A detailed picture of the Anti-h ... Read More

• Anti-Epileptic Drugs/Epilepsy - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Anti-Epileptic Drugs/Epilepsy - Pipeline Insight, 2024 Anti-Epileptic Drugs/Epilepsy Overview ""Anti-Epileptic Drugs/Epilepsy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Anti-Epileptic Drugs/E ... Read More

• Anaplastic Thyroid Cancer - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anaplastic Thyroid Cancer - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Thyroid Cancer - Pipeline Insight, 2024,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Anaplastic Thyroid Cancer pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More

• Allergic Bronchopulmonary Aspergillosis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Allergic Bronchopulmonary Aspergillosis - Pipeline Insight, 2024 Allergic Bronchopulmonary Aspergillosis Overview ""Allergic Bronchopulmonary Aspergillosis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects acr ... Read More

• Chronic Hepatitis B Virus Infection - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Chronic Hepatitis B Virus Infection - Pipeline Insight, 2024 DelveInsight’s, “Chronic Hepatitis B Virus Infection - Pipeline Insight, 2024,” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Chronic Hepatitis B Virus Infection pipeline landscape. It covers the pi ... Read More

• Chronic Myeloid Leukemia - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Chronic Myeloid Leukemia - Pipeline Insight, 2024 DelveInsight’s, “Chronic Myeloid Leukaemia- Pipeline Insight, 2024,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Myeloid Leukaemia pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More

• Chronic lymphocytic leukemia- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Chronic lymphocytic leukemia- Pipeline Insight, 2024 DelveInsight’s, “Chronic lymphocytic leukemia- Pipeline Insight, 2024” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic lymphocytic leukemia pipeline landscape. It covers the pipeline drug profiles, incl ... Read More

• Anal Cancer - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Anal Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Anal cancer is relatively uncommon, accounting for about 2.7% of all reported gastrointestinal cancers in the United States. Anal cancer is more prevalent among women than men and is most frequently diagnosed betwee ... Read More

• Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The market size of ALS in 2023, in the 7MM was ALS ~ USD 1,000 million. The current standard of care that involves the prescription of riluzole has been effective in slowing the disease ... Read More

• Cervical Cancer - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Cervical Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The US accounted for the largest market size of cervical cancer, i.e., nearly USD 530 million in 2023. Cervical cancer is most often diagnosed between the ages of 35 and 44. The average age of diagnosis in the U ... Read More

• Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034 Key Highlights wAIHA is the most common type of autoimmune hemolytic anemia. People of any age, including children, may develop wAIHA, but it is more common among adults, with a peak incidence between 50 and 70 years. The median ... Read More

• Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,500

  Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights The main treatment options for ALL include chemotherapy, targeted therapy, immunotherapy, surgery, radiation therapy, and stem cell transplant. In 2021, the market size of ALL in the 7MM was app ... Read More

• Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, in the 7MM the total market size of wAIHA was ~ USD 300 million. wAIHA is the most common type of autoimmune hemolytic anemia, comprising nearly 70–80% of all adult cases and 50% of pediatric ... Read More

• Parainfluenza Virus Infection Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Parainfluenza Virus Infection Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Acute Respiratory Distress Syndrome (ARDS) is a critical condition characterized by the rapid onset of respiratory failure due to extensive inflammation in the lungs. This syndrome can arise from var ... Read More

• CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,500

  CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Urinary tract infections (UTIs) are amongst the most frequent bacterial infections. They can manifest clinically in various ways, from relatively benign, uncomplicated i ... Read More

• Hemophilia B - Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Hemophilia B - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia B - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Hemophilia B pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

• Advanced Renal Cell Carcinoma- Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Advanced Renal Cell Carcinoma- Pipeline Insight, 2024 DelveInsight’s, “Advanced Renal Cell Carcinoma- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the pipeline drug profiles, i ... Read More

• Diabetes Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 4,250

  Diabetes Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Diabetes Drug Market By Drug Type (Insulin, Non-Insulin Drugs, Combination Drugs, And Others), Route Of Administration (Oral, Intravenous, And Subcutaneous), Distribution Channel (Offline And Online) and geogr ... Read More

• Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024 DelveInsight’s, “Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Non-Small-Cell Lung cancer (NSCLC) pipeline landscape. It covers the pipel ... Read More

• Biliary Tract Cancers (BTCs) - Market Insight, Epidemiology And Market Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Biliary Tract Cancers (BTCs) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights CAR T-cell therapy has transformed the treatment of aggressive lymphomas such as DLBCL and is now a viable option for RR-FL; however, follow-up remains limited. Identifying appropriate patients for ... Read More

• Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Dry AMD has the potential to progress to geographic atrophy, a stage characterized by irreversible vision loss caused by the depletion of crucial retinal components such as retinal pigment epithelium (R ... Read More

• Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of hemophilia A was the largest in the US among the 7MM, accounting for approximately USD 5,000 million, which is further expected to increase by 2034. In September 2023, concizumab wa ... Read More

• Hemophilia A - Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Hemophilia A - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia A - Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hemophilia A pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

• HER2 Negative Breast Cancer- Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  HER2 Negative Breast Cancer- Pipeline Insight, 2024 DelveInsight’s, “HER2 Negative Breast Cancer- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2 Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles, includi ... Read More

< prev 14 15 16 17 18 19 20 21 22 23 next >